FDA flags safety risk with Boston Scientific stents after reports of deployment issues causing deaths and injuries, prompting a Class I recall.

Boston Scientific Corp BSX on Wednesday initiated the removal of certain AXIOS Stents and Electrocautery-Enhanced Delivery Systems from clinical settings following reports of deployment complications ...

Boston Scientific has issued an FDA warning letter recommending removal of 1,660 lots of AXIOS Stent and Electrocautery Enhanced Delivery Systems due to increased reports of stent deployment and ...

Add Yahoo as a preferred source to see more of our stories on Google. Boston Scientific's headquarters is in Marlborough, Massachusetts. (Courtesy of Boston Scientific) This story was originally ...

The FDA sent an early safety alert warning clinicians of deployment failures with certain Boston Scientific AXIOS Stent and Electrocautery Enhanced Delivery Systems that have been linked to three ...

Please provide your email address to receive an email when new articles are posted on . Boston Scientific has launched the Axios Stent and Electrocautery Enhanced Delivery System for the endoscopic ...

The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery ...